Researchmoz Global Pvt. Ltd.

Global Stem Cell Umbilical Cord Blood Market to Grow at a CAGR of 30.36% over Forecast 2015-2019

ResearchMoz added Latest Research Report titled " Global Stem Cell Umbilical Cord Blood Market 2015-2019: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report " to it's Large Report database.

 

Albany, NY -- (SBWIRE) -- 07/29/2016 -- UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic and genetic disorders. The placental blood can produce 10 times more quantity of stem cells compared to the umbilical cord, which can in turn be used for the treatment of an adult patient. The cord blood that is collected during the childbirth is stored and cryopreserved. The storage of the cord blood can be done at private cord blood banks or public cord blood banks. This preserved blood can be used for the transplantation, and treatment of diseases at the later stages of life.

The global stem cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019. The report covers the present scenario and the growth prospects of the global stem cell UCB market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the banking and utilization of UCB stem cells for the treatment of various disorders, such as cancers, blood disorders, metabolic disorders, immune diseases, and others.

Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=326771

Technavio's report, Global Stem Cell UCB Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global stem cell UCB market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
- Americas
- APAC
- EMEA

Key Vendors
- Caladrius Biosciences
- Celgene
- Mesoblast
- Pluristem Therapeutics

Other Prominent Vendors
- Athersys
- CHA Bio & Diostech
- Cytori Therapeutics
- Nuo Therapeutics
- Ocata Therapeutics
- Opexa Therapeutics
- Osiris Therapeutics
- Teva Pharmaceuticals
- United Therapeutics

Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=326771

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: 518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG